Atherosclerosis
Volume 199, Issue 2 , Pages 378-383 , August 2008

Increased Adiponectin synthesis in the visceral adipose tissue in men with coronary artery disease treated with pravastatin: A role of the attenuation of oxidative stress

  • Shin Saito

      Affiliations

    • Division of Cardiology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, Japan
  • ,
  • Takayuki Fujiwara

      Affiliations

    • Division of Cardiology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, Japan
  • ,
  • Toshiro Matsunaga

      Affiliations

    • Division of Cardiology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, Japan
  • ,
  • Kazuyuki Minagawa

      Affiliations

    • Division of Thoracic and Cardiovascular Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
  • ,
  • Kouzo Fukui

      Affiliations

    • Division of Thoracic and Cardiovascular Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
  • ,
  • Ikuo Fukuda

      Affiliations

    • Division of Thoracic and Cardiovascular Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
  • ,
  • Tomohiro Osanai

      Affiliations

    • Division of Cardiology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, Japan
  • ,
  • Ken Okumura

      Affiliations

    • Division of Cardiology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 17239 5057; fax: +81 17235 9190.

Received 16 July 2007 ,Revised 21 October 2007 ,Accepted 9 November 2007.

References 

  1. Larsson B, Svärdsudd K, Welin L, et al. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J. 1984;288:1401–1404
  2. Nakajima T, Fujioka S, Tokunaga K, Matsuzawa Y, Tarui S. Correlation of intraabdominal fat accumulation and left ventricular performance in obesity. Am J Cardiol. 1989;64:369–373
  3. Nakamura T, Tokunaga K, Shimomura I, et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis. 1994;107:239–246
  4. Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002;13:134–141
  5. Osaka CAD Study Group. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscrler Thromb Vasc Biol. 2003;23:85–89
  6. Hattori S, Hattori Y, Kasai K. Hypoadiponectinemia is caused by chronic blockade of nitric oxide synthesis in rats. Metabolism. 2005;54:482–487
  7. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004;109:39–43
  8. Sakamoto K, et al. The effect of 6 months of treatment with pravastatin on serum adiponectin concentrations in Japanese patients with coronary artery disease and hypercholesterolemia: a pilot study. Clin Ther. 2006;28:1012–1021
  9. Fleming I, Michaelis UR, Bredenkötter D, et al. Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res. 2001;88:44–51
  10. Steinberg D, Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation. 1997;95:1062–1071
  11. Davies KJ, Lin SW, Pacifici RE. Protein damage and degradation by oxygen radicals. J Biol Chem. 1987;262:9914–9920
  12. Stadtman ER. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu Rev Biochem. 1993;62:797–821
  13. Prevention of diabetes mellitus. Report of WHO Study Group. World Health Organ Tech Rep Ser 1994;844:1–100.
  14. Nishizawa H, Shimomura I, Kishida K, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002;51:2734–2741
  15. Nakamura Y, Shimada K, Fukuda D, et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart. 2004;90:528–533
  16. Yamamoto Y, Hirose H, Saito I, et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci. 2002;103:137–142
  17. Iwashima Y, Katsuya T, Ishikawa K, et al. Association of hypoadiponectinemia with smoking habit in men. Hypertension. 2005;45:1094–1100
  18. Miyazaki T, Shimada K, Mokuno H, Daida H. Adipocyte derived plasma protein, adiponectin, is associated with smoking status in patients with coronary artery disease. Heart. 2003;89:663
  19. Gannagé-Yared MH, Azar RR, Amm-Azar M, et al. Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients. Metabolism. 2005;54:947–951
  20. Baker AR, Silva NF, Quinn DW, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006;13(5):1
  21. Lihn AS, Bruun JM, He G, et al. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol. 2004;219:9–15
  22. Soares AF, Guichardant M, Cozzone D, et al. Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-1 adipocytes. Free Radic Biol Med. 2005;38:882–889
  23. Okamoto Y, Higashiyama H, Rong JX, et al. Comparison of mitochondrial and macrophage content between subcutaneous and visceral fat in db/db mice. Exp Mol Pathol. 2007;83:73–83
  24. Maeda N, Takahashi M, Funahashi T, et al. PPAR gamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 2001;50:2094–2099
  25. Fasshauer M, Kralisch S, Klier M, et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2003;301:1045–1050
  26. Bruun JM, Lihn AS, Verdich C, et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab. 2003;285:527–533
  27. Osei K, Gaillard T, Cook C, et al. Discrepancies in the regulation of plasma adiponectin and TNF-alpha levels and adipose tissue gene expression in obese African Americans with glucose intolerance: a pilot study using rosiglitazone. Ethn Dis. 2005;15:641–648
  28. Hata Y, et al. Report of the Japan Atherosclerosis Society (JAS) Guideline for diagnosis and treatment of hyperlipidemia in Japanese adults. J Atheroscler Thromb. 2002;9:1–27

PII: S0021-9150(07)00737-X

doi: 10.1016/j.atherosclerosis.2007.11.010

Atherosclerosis
Volume 199, Issue 2 , Pages 378-383 , August 2008